Author's reply to Borg et al. Comment on: "EU's new pharmacovigilance legislation: Considerations for biosimilars"
ISSN: 1179-1942, 0114-5916
Année de publication: 2014
Volumen: 37
Número: 2
Pages: 125-126
Type: Lettre
ISSN: 1179-1942, 0114-5916
Année de publication: 2014
Volumen: 37
Número: 2
Pages: 125-126
Type: Lettre